Hamps Bio IPO is a fixed-price issue worth ₹6.22 crores. The issue consists entirely of a fresh issue of 12.2 lakh shares.
The subscription for the Hamps Bio IPO will open on December 13, 2024, and close on December 17, 2024. The allotment of shares is expected to be finalized on Wednesday, December 18, 2024. The IPO is scheduled to list on the BSE SME platform, with the tentative listing date set for Friday, December 20, 2024.
Hamps Bio operates in the pharmaceutical sector, specifically focusing on the ethical marketing and distribution of pharmaceutical formulation products. They offer a wide range of products, including tablets, syrups, capsules, injectables, oils, gels, and powders used as medicines and nutritional supplements. Additionally, they manufacture freeze-dried and frozen products such as fruits, vegetables, herbs, and flowers.
The fixed price for the Hamps Bio IPO is ₹51 per share. Investors must apply for a minimum lot size of 2,000 shares, which requires a minimum investment of ₹102,000 for retail investors. High Net-worth Individuals (HNIs) must invest in at least two lots, or 4,000 shares, amounting to ₹204,000.
Marwadi Chandarana Intermediaries Brokers Pvt. Ltd. is the book-running lead manager for this IPO, while Bigshare Services Pvt Ltd serves as the registrar. Pure Broking is the designated market maker for the Hamps Bio IPO.
Hamps Bio IPO Details:
| Company Name | Hamps Bio Limited |
| Sector | Pharmaceutical |
| IPO Type | SME |
| IPO Open date | 13th Dec 2024 |
| IPO Close date | 17th Dec 2024 |
| OFS | |
| Listing Exchanges | BSE |
| Share Holding Pre-issue | |
| DRHP Draft Prospectus | Click to check |
| RHP Draft Prospects | Click to check |
Hamps Bio IPO Lot Size:
| Application | Lot Size | Shares | Amount |
| Retail (Min) | 1 | 2000 | 1,02,000 |
| HNI (Min) | 2 | 4000 | 2,04,000 |
Hamps Bio IPO Timeline:
| IPO Open Date | 13th Dec 2024 |
| IPO Close Date | 17th Dec 2024 |
| Basis of Allotment | 18th Dec 2024 |
| Refund Initiation Date | 19th Dec 2024 |
| Shares Credit to Demat | 19th Dec 2024 |
| Listing Date | 20th Dec 2024 |
Things to Consider before applying for an IPO
Financial Performance: Review Hamps Bio’s Financials to understand its revenue, profitability, and growth prospects.
Industry Outlook: Consider the overall health of India’s Pharmaceutical Industry.
Valuation: Compare the price band to similar companies in the industry to see if the IPO is priced fairly.
Management Team: Research the experience and capabilities of the management team.
Our Verdict
This IPO offers a good opportunity to invest in Hamps Bio and be a part of its growth.
FAQ
What is Grey Market Premium (GMP)?
The Grey Market Premium (GMP) represents the price at which an Initial Public Offering (IPO) is traded in the unregulated grey market before its official listing. It serves as an indicator of how the IPO might perform on the listing day. Seeing the latest GMP, investors can estimate the listing performance of the IPO.
